Pfizer pushes generics worldwide

Big Pharma continues to look toward generics and emerging markets to fuel growth. Pfizer Inc. (New York) has entered into licensing agreements with two Indian pharmaceutical companies, simultaneously expanding its generic portfolio and strengthening its position in emerging markets, according […]

Read More

Performance-based pharma pricing comes to US payers

An agreement that bases Merck’s diabetes drug pricing on how well patients’ blood-sugar control (A1C levels) improves has been signed with Cigna (Bloomfield, CT). In an interesting twist, though, this pay-for-performance agreement gives Cigna bigger discounts for better patient health—in […]

Read More

Retail-PBM combination is working for CVS Caremark

The pharmacy benefit management (PBM) business of CVS Caremark Corp. outpaced the pharmacy side in first-quarter figures released by the Woonsocket, RI-based prescription drug provider. PBM network revenues climbed 6.8% in the quarter, according to an announcement. The company says […]

Read More